Latest: FDA Approves New Biosimilar for Oncology Treatment
Neurology

Target Trial Emulation Favors Rituximab’s Effectiveness Over Cladribine in Treating Multiple Sclerosis

by Neurology Live
0 Comments
0 Mins
A new study reveals rituximab outperforms cladribine in managing MRI disease activity in relapsing multiple sclerosis over 4.5 years.
Tags:
Neurology Live
Author

Neurology Live

Previous Post
What could be the cause of this patient’s apparent ‘gastric flu’ symptoms?
Next Post
Research: $3.8M NIH Grant to Study Childhood Protein as COPD Predictor
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago